Wellous
HomeMeRewardsReviewsProfilePolicy NoticeTerms & Conditions

After taking Moveon for 10 days, I found improvement on my knees. There is also no more pain walking upstairs. Being convinced that the product works, I have now purchased 5 carton of Moveon and 2 carton of Liveon. In addition, I am gifted with another carton of Moveon.

After taking Moveon for 10 days, I found improvement on my knees. There is also no more pain walking upstairs. Being convinced that the product works, I have now purchased 5 carton of Moveon and 2 carton of Liveon. In addition, I am gifted with another carton of Moveon.

Not everyone gains weight for the same reason 👀

Not everyone gains weight for the same reason 👀

That’s why the same method doesn’t work for everyone either.

In this video, Ember breaks down the 3 groups that may benefit most from this system — and how each body responds differently.

Want to know which one sounds like you? 💜

#ZENSO
#ZENSOGLPro

Suggested For You

Happy Mother's Day.

Happy Mother's Day.

Thank you for your boundless love, strength, and the little things you do every day that make life so much brighter.

At WellFam Club, we believe in nurturing what matters — health, happiness, and family.

Today, we celebrate you — the heart of every home.

WellFam Update!

WellFam Update!

We couldn't be prouder. Incredibly honored and excited to bring home the Outstanding ESG Practice Award at the China Press Outstanding Elite Awards.

To the amazing teams—R&D, corporate, creative, and leadership—for driving our sustainability vision forward and making it happen 💪✨

This isn’t the finish line—it’s just the beginning of our journey toward a brighter, greener future together!

你知道吗?🤔 将近 40% 马来西亚成年人患有非酒精性脂肪肝(NAFLD),这也是马来西亚最常见的肝脏疾病。

你知道吗?🤔 将近 40% 马来西亚成年人患有非酒精性脂肪肝(NAFLD),这也是马来西亚最常见的肝脏疾病。

我们最新一期的时事简报将带你深入探讨肝脏健康!本期的资讯内容涵盖了一系列常见的肝脏疾病,探索了预防病毒性肝炎和脂肪肝的方法,以及我们本期的重点产品 - LIVETAL 和 HOMEGA,为你的肝脏健康助力加持!还有,也别错过了试试我们这期的数字排毒挑战,让自己暂时“退出”数字世界,全面地身心放松!🧡✨

点击下方链接查看完整的时事简报,了解更多关于保持肝脏健康的知识吧!🥰

👉 https://cdn.wellous.com/membership/article/newsletter/2024/2024-q2-cn.pdf